https://www.selleckchem.com/pr....oducts/iruplinalkib.
Desmoid tumor (DT; other synonymously used terms Desmoid-type fibromatosis, aggressive fibromatosis) is a rare and locally aggressive monoclonal, fibroblastic proliferation characterised by a variable and often unpredictable clinical course. Previously surgery was the standard primary treatment modality; however, in recent years a paradigm shift towards a more conservative management has been introduced and an effort to harmonise the strategy amongst clinicians has been made. We present herein an evidence-based, joint global consen
Curtir
Comentario
Compartilhar
